Long-term results with elective cyclosporine withdrawal at three months after renal transplantation--appropriate for living-related transplants.
Kahn
D
D
Department of Surgery and Medicine, Groote Schuur Hospital, University of Cape Town, South Africa.
Ovnat
A
A
Pontin
A R
AR
Swanepoel
C R
CR
Cassidy
M J
MJ
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000592:standards / Q000627:therapeutic use; D002102:Cadaver; D002648:Child; D016572:Cyclosporine / Q000009:adverse effects / Q000592:standards / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005192:Family Health; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D017048:Health Care Costs; D006801:Humans; D015994:Incidence; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000191:economics / Q000276:immunology; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014019:Tissue Donors
D016572:Cyclosporine; D001379:Azathioprine